Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
SUBSCRIBE
Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
Global Market Bulletin
No Result
View All Result
Home Stock Market News

Top 10 Cheap AI Small-Cap Stocks to Buy Now

by Global Market Bulletin
February 26, 2026
in Stock Market News
0
Top 10 Cheap AI Small-Cap Stocks to Buy Now

Top 10 Cheap AI Small-Cap Stocks to Buy Now

655
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

3. Veritone Inc. (NASDAQ:VERI)

Price per Share: $2.96
Market Cap: $271.746M

You might also like

5 Stocks With Billion-Dollar Potential You Should Not Miss

10 Stocks With Billion-Dollar Potential You Should Not Miss

Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

Veritone, Inc. claimed the 3rd spot in our list of the top 10 cheap AI small-cap stocks to buy now. The company is steadily reinforcing its position as a differentiated enterprise AI platform at a time when investors are aggressively re-rating artificial intelligence stocks tied to real revenue use cases rather than speculative hype. The recent multi-year renewal with U.S. Soccer underscores this distinction. By extending its agreement to license audiovisual content for the U.S. Women’s and Men’s National Teams, Youth National Teams, and Extended National Teams, Veritone has secured another validation of its AI-powered content monetization model, strengthening the long-term bull case for VERI stock as a scalable digital asset management and AI licensing platform.

At the center of this investment thesis is Veritone’s aiWARE and Veritone Digital Media Hub, which transform massive sports archives into searchable, monetizable digital assets. Through advanced metadata tagging, AI-driven content indexing, and turnkey e-commerce licensing capabilities, Veritone enables broadcasters, ad agencies, production studios, and global brands to access iconic U.S. Soccer footage with speed and precision. This is not simply a software subscription story; it is a recurring revenue content licensing engine built on enterprise AI infrastructure. As global sports properties increasingly seek to unlock incremental revenue from archival footage, Veritone’s AI solutions position the company at the intersection of artificial intelligence, digital media, and intellectual property monetization.

For investors evaluating small-cap AI stocks on the NASDAQ, the importance of this renewal lies in its durability and strategic depth. The agreement confirms Veritone as a long-term technology partner embedded in U.S. Soccer’s content strategy, enabling the organization to maintain control of its intellectual property while leveraging AI-powered archiving, searchability, and licensing to generate new revenue streams. The company’s ability to identify unauthorized content usage across social media platforms further enhances monetization potential, reinforcing Veritone’s role not only as a content distributor but as a revenue optimization partner in the sports media ecosystem.

From a broader market perspective, Veritone operates in high-growth verticals including enterprise AI software, media technology, advertising analytics, and government and public sector AI solutions. As artificial intelligence adoption accelerates and organizations demand scalable AI data platforms with measurable ROI, Veritone’s expanding roster of enterprise clients and multi-year agreements support the narrative that VERI stock is transitioning from a speculative AI play to a more fundamentals-driven growth story. The U.S. Soccer renewal demonstrates tangible revenue visibility, strengthens brand credibility, and highlights the company’s ability to convert proprietary AI technology into repeatable, monetizable workflows. If Veritone continues to scale enterprise contracts and deepen its content licensing pipeline, the current valuation may not fully reflect the long-term earnings leverage embedded in its AI-powered digital media platform.

Click next to see the following stock...

Page 4 of 6
Prev1...3456Next
Tags: AudioEye Inc. (NASDAQ:AEYE)BigBear.ai Holdings Inc. (NYSE:BBAI)Duos Technologies Group Inc. (NASDAQ:DUOT)FiscalNote Holdings Inc. (NYSE:NOTE)Five9 Inc. (NASDAQ:FIVN)Knightscope Inc. (NASDAQ:KSCP)Nauticus Robotics Inc. (NASDAQ:KITT)Serve Robotics Inc. (NASDAQ:SERV)SoundHound AI Inc. (NASDAQ: SOUN)Top 10 Best AI Small-Cap Stocks to Buy NowVeritone Inc. (NASDAQ:VERI)
Share262Tweet164

Global Market Bulletin

Global Market Bulletin is a leading provider of stock market updates, economic news, and personalized investing guides. Our team brings you the latest global financial information to help you make smart investment decisions. About the Editorial Team Our editorial team consists of financial experts and seasoned market analysts who bring decades of experience to our coverage. With a commitment to unbiased reporting, our team ensures that every article is backed by thorough research and delivers accurate financial insights.

Recommended For You

5 Stocks With Billion-Dollar Potential You Should Not Miss

by Global Market Bulletin
July 25, 2026
0
5 Stocks With Billion-Dollar Potential You Should Not Miss

In this article, we will take a look at the 5 Stocks With Billion-Dollar Potential You Should Not Miss. For investors looking for the complete list, you can...

Read moreDetails

10 Stocks With Billion-Dollar Potential You Should Not Miss

by Global Market Bulletin
July 25, 2026
0
10 Stocks With Billion-Dollar Potential You Should Not Miss

In this article, we will take a look at the 10 Stocks With Billion-Dollar Potential You Should Not Miss. Wall Street ended the week caught between optimism and...

Read moreDetails

Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

by Global Market Bulletin
July 18, 2026
0
Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Is Lexeo Therapeutics (LXEO) a Good Gene Therapy Stock for Long-Term Growth?

by Global Market Bulletin
July 18, 2026
0
Is Lexeo Therapeutics (LXEO) a Good Gene Therapy Stock for Long-Term Growth?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Is Sagimet Biosciences (SGMT) a Promising Biotech Stock to Buy Before Its Next Catalyst?

by Global Market Bulletin
July 18, 2026
0
Is Sagimet Biosciences (SGMT) a Promising Biotech Stock to Buy Before Its Next Catalyst?

We recently published our article 5 Stocks Under $10 Analysts Believe Could Soar 200%. To read the full story, you can go directly to 10 Stocks Under $10...

Read moreDetails

Browse by Category

  • CEO Interviews
  • Economy
  • Investing
  • Stock Market News
  • Uncategorized

QUICK LINKS

  • Stock Market News
  • Investing
  • Economy
  • Contact Us
  • About Global Market Bulletin
  • Editorial Policy – Global Market Bulletin
  • Our Editorial Team

RECENT POSTS

  • 5 Stocks With Billion-Dollar Potential You Should Not Miss
  • 10 Stocks With Billion-Dollar Potential You Should Not Miss
  • Could ARS Pharmaceuticals (SPRY) Disrupt the Emergency Allergy Treatment Market?

GET EMAIL MARKET UPDATES

Subscribe to our mailing list to receives daily updates direct to your inbox!
  • Privacy Policy
  • Terms and Conditions

© 2022 Global Market Bulletin. All Rights Reserved.

No Result
View All Result
  • Home
  • Stock Market News
  • Investing
  • Economy

© 2022 Global Market Bulletin. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?